Literature DB >> 7909035

Extra incidence caused by mammographic screening.

R Boer, P Warmerdam, H de Koning, G van Oortmarssen.   

Abstract

Mesh：

Year:  1994        PMID： 7909035     DOI： 10.1016/s0140-6736(94)90105-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  19 in total

1.  An investigation of the apparent breast cancer epidemic in France: screening and incidence trends in birth cohorts.

Authors:  Bernard Junod; Per-Henrik Zahl; Robert M Kaplan; Jørn Olsen; Sander Greenland
Journal:  BMC Cancer       Date:  2011-09-21       Impact factor: 4.430

2.  Evaluating new screening tests for breast cancer.

Authors:  Les Irwig; Nehmat Houssami; Bruce Armstrong; Paul Glasziou
Journal:  BMJ       Date:  2006-03-25

Review 3.  The value of models in informing resource allocation in colorectal cancer screening: the case of The Netherlands.

Authors:  Frank van Hees; Ann G Zauber; Harriët van Veldhuizen; Marie-Louise A Heijnen; Corine Penning; Harry J de Koning; Marjolein van Ballegooijen; Iris Lansdorp-Vogelaar
Journal:  Gut       Date:  2015-06-10       Impact factor: 23.059

4.  Quantitative estimates of the impact of sensitivity and specificity in mammographic screening in Germany.

Authors:  P G Warmerdam; H J de Koning; R Boer; P M Beemsterboer; M L Dierks; E Swart; B P Robra
Journal:  J Epidemiol Community Health       Date:  1997-04       Impact factor: 3.710

5.  Overdiagnosis in organised mammography screening in Denmark. A comparative study.

Authors:  Karsten J Jørgensen; Per-Henrik Zahl; Peter C Gøtzsche
Journal:  BMC Womens Health       Date:  2009-12-22       Impact factor: 2.809

6.  Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study.

Authors:  Per-Henrik Zahl; Bjørn Heine Strand; Jan Maehlen
Journal:  BMJ       Date:  2004-03-10

Review 7.  Lead-time models should not be used to estimate overdiagnosis in cancer screening.

Authors:  Per-Henrik Zahl; Karsten Juhl Jørgensen; Peter C Gøtzsche
Journal:  J Gen Intern Med       Date:  2014-03-04       Impact factor: 5.128

Review 8.  Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends.

Authors:  Karsten Juhl Jørgensen; Peter C Gøtzsche
Journal:  BMJ       Date:  2009-07-09

9.  Overdiagnosis in screening mammography in Denmark: population based cohort study.

Authors:  Sisse Helle Njor; Anne Helene Olsen; Mogens Blichert-Toft; Walter Schwartz; Ilse Vejborg; Elsebeth Lynge
Journal:  BMJ       Date:  2013-02-26

10.  Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis.

Authors:  P-H Zahl; K J Jørgensen; P C Gøtzsche
Journal:  Br J Cancer       Date:  2013-08-20       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.